These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14644584)

  • 1. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization.
    Castro C; Sánchez E; Delgado A; Soriano I; Núñez P; Baro M; Perera A; Evora C
    J Control Release; 2003 Dec; 93(3):341-54. PubMed ID: 14644584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-month ciprofloxacin implants for multibacterial bone infections.
    Castro C; Evora C; Baro M; Soriano I; Sánchez E
    Eur J Pharm Biopharm; 2005 Aug; 60(3):401-6. PubMed ID: 15996581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-in vivo characterization of gentamicin bone implants.
    Baro M; Sánchez E; Delgado A; Perera A; Evora C
    J Control Release; 2002 Oct; 83(3):353-64. PubMed ID: 12387944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of crosslinked high amylose starch matrix implants. 2. In vivo release of ciprofloxacin.
    Désévaux C; Lenaerts V; Girard C; Dubreuil P
    J Control Release; 2002 Jul; 82(1):95-103. PubMed ID: 12106980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ciprofloxacin implants in treating experimental osteomyelitis.
    Alvarez H; Castro C; Moujir L; Perera A; Delgado A; Soriano I; Evora C; Sánchez E
    J Biomed Mater Res B Appl Biomater; 2008 Apr; 85(1):93-104. PubMed ID: 17696153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.
    Ramchandani M; Robinson D
    J Control Release; 1998 Jul; 54(2):167-75. PubMed ID: 9724903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
    Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT
    Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of crosslinked high amylose starch matrix implants. 1. In vitro release of ciprofloxacin.
    Désévaux C; Dubreuil P; Lenaerts V
    J Control Release; 2002 Jul; 82(1):83-93. PubMed ID: 12106979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler.
    Mäkinen TJ; Veiranto M; Lankinen P; Moritz N; Jalava J; Törmälä P; Aro HT
    J Antimicrob Chemother; 2005 Dec; 56(6):1063-8. PubMed ID: 16234335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique.
    Pham HH; Luo P; Génin F; Dash AK
    AAPS PharmSciTech; 2002; 3(1):E1. PubMed ID: 12916954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment.
    Koort JK; Suokas E; Veiranto M; Mäkinen TJ; Jalava J; Törmälä P; Aro HT
    J Biomed Mater Res A; 2006 Sep; 78(3):532-40. PubMed ID: 16736479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of calcium phosphates/poly (d,l-lactide) blends containing gentamicin for bone implantation.
    Soriano I; Evora C
    J Control Release; 2000 Jul; 68(1):121-34. PubMed ID: 10884585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of ciprofloxacin into bone: a new bioabsorbable implant.
    Overbeck JP; Winckler ST; Meffert R; Törmälä P; Spiegel HU; Brug E
    J Invest Surg; 1995; 8(3):155-62. PubMed ID: 7547723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of an antibiotic in poly(lactic acid) and polypropylene by melt processing.
    Scaffaro R; Botta L; Maio A; Gallo G
    J Appl Biomater Funct Mater; 2016 Jul; 14(3):e240-7. PubMed ID: 27311432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants.
    Sánchez E; Baro M; Soriano I; Perera A; Evora C
    Eur J Pharm Biopharm; 2001 Sep; 52(2):151-8. PubMed ID: 11522480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections.
    Benoit MA; Mousset B; Delloye C; Bouillet R; Gillard J
    Int Orthop; 1997; 21(6):403-8. PubMed ID: 9498152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vivo bioactivity and compressive strength of a novel superporous hydroxyapatite with beta-tricalcium phosphates.
    Okanoue Y; Ikeuchi M; Takemasa R; Tani T; Matsumoto T; Sakamoto M; Nakasu M
    Arch Orthop Trauma Surg; 2012 Nov; 132(11):1603-10. PubMed ID: 22760581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of ciprofloxacin microspheres in eradicating bacterial biofilm.
    Owusu-Ababio G; Rogers J; Anwar H
    J Control Release; 1999 Feb; 57(2):151-9. PubMed ID: 9971894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo efficiency of antimicrobial inorganic bone grafts in osteomyelitis treatments.
    Mestres G; Fernandez-Yague MA; Pastorino D; Montufar EB; Canal C; Manzanares-Céspedes MC; Ginebra MP
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():84-95. PubMed ID: 30678975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design of flexible ciprofloxacin-loaded PLGA implants using a reversed phase separation/coacervation method.
    Park PI; Makoid M; Jonnalagadda S
    Eur J Pharm Biopharm; 2011 Feb; 77(2):233-9. PubMed ID: 21145965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.